(Q39113964)

English

Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures

scientific article published on December 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Naturally-occurring human serum antibodies to inner core lipopolysaccharide epitopes of Neisseria meningitidis protect against invasive meningococcal disease caused by isolates displaying homologous inner core structures (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

lipopolysaccharide

0 references

Neisseria meningitidis

1 reference

based on heuristic

inferred from title

D-Glcp-(1->3)-[alpha-D-GlcpNAc-(1->2)]-6-PEA-L-alpha-D-Hepp-(1->3)-L-alpha-D-Hepp-(1->5)-[alpha-Kdo-(2->4)]-alpha-Kdo

1 reference

ChEBI release 2020-05-28

1 reference

based on heuristic

inferred from title

meningococcal disease

1 reference

based on heuristic

inferred from title

Katherine Makepeace

4

object named as

Katherine Makepeace

0 references

10

object named as

E Richard Moxon

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

author name string

Anne Jäkel

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Joyce S Plested

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

J Claire Hoe

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Katherine Makepeace

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Margaret-Anne J Gidney

5

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Suzanne Lacelle

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Frank St Michael

7

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Andrew D Cox

8

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

James C Richards

9

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

language of work or name

0 references

publication date

1 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

6655-6663

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococc

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Immunization with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Immunization with the recombinant PorB outer membrane protein induces a bactericidal immune response against Neisseria meningitidis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Genetic basis for biosynthesis, structure, and function of meningococcal lipooligosaccharide (endotoxin)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

The structure of an R-type oligosaccharide core obtained from some lipopolysaccharides of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Structural basis of the Neisseria meningitidis immunotypes including the L4 and L7 immunotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Lipo-oligosaccharide immunotyping of Neisseria meningitidis by a whole-cell ELISA with monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Structure of an alpha-2,6-sialylated lipooligosaccharide from Neisseria meningitidis immunotype L1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Structural analysis of the lipopolysaccharide from Neisseria meningitidis strain BZ157 galE: localisation of two phosphoethanolamine residues in the inner core oligosaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Identification of a gene (lpt-3) required for the addition of phosphoethanolamine to the lipopolysaccharide inner core of Neisseria meningitidis and its role in mediating susceptibility to bactericidal killing and opsonophagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

lpt6, a gene required for addition of phosphoethanolamine to inner-core lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

The genetic basis of the phase variation repertoire of lipopolysaccharide immunotypes in Neisseria meningitidis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Human immunity to the meningococcus. I. The role of humoral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Immune response of infants and children to disseminated infections with Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Cloning and molecular analysis of the galE gene of Neisseria meningitidis and its role in lipopolysaccharide biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Analysis of the icsBA locus required for biosynthesis of the inner core region from Neisseria meningitidis lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Molecular analysis of a locus for the biosynthesis and phase-variable expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Development, characterization, and functional activity of a panel of specific monoclonal antibodies to inner core lipopolysaccharide epitopes in Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Preparation of glycoconjugates by dialkyl squarate chemistry revisited

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Colorimetric Method for Determination of Sugars and Related Substances

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Enzyme linked immunosorbent assay (ELISA) for the detection of serum antibodies to the inner core lipopolysaccharide of Neisseria meningitidis group B

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Highly ConservedNeisseria meningitidisInner‐Core Lipopolysaccharide Epitope Confers Protection against Experimental Meningococcal Bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Neisserial lipooligosaccharide is a target for complement component C4b. Inner core phosphoethanolamine residues define C4b linkage specificity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Affinity-purified human immunoglobulin G that binds a lacto-N-neotetraose-dependent lipooligosaccharide structure is bactericidal for serogroup B Neisseria meningitidis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Carriage of Neisseria meningitidis and Neisseria lactamica in Infants and Children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Genetic diversity and carriage dynamics of Neisseria lactamica in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Structural and immunochemical characterization of the lipooligosaccharides expressed by Neisseria subflava 44

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Identification of the gene (lgtG) encoding the lipooligosaccharide beta chain synthesizing glucosyl transferase from Neisseria gonorrhoeae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Immunity to Neisseria meningitidis group B in adults despite lack of serum bactericidal antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.041

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.09.041

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

release_6z2gnstuxfdo5pfzwhpksm26ai

1 reference

https://api.fatcat.wiki/v0/release/6z2gnstuxfdo5pfzwhpksm26ai

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39113964&oldid=1905267185"